Hirsutism surgery
Jump to navigation
Jump to search
|
Hirsutism Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Medical Therapy |
|
Case Studies |
|
Hirsutism surgery On the Web |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ogheneochuko Ajari, MB.BS, MS [2], Rasam Hajiannasab M.D.[3], Eiman Ghaffarpasand, M.D. [4]
Overview
The mainstay of treatment for hirsutism is medical therapy. Surgery is usually reserved for patients with either ovarian tumor, adrenal tumor, perimenopausal or postmenopausal women with severe hyperandrogenism who are candidated for oophorectomy, or bariatric surgery for severe obesity.
Surgery
| PF2LH6CuesY|500}} |
- The mainstay of treatment for hirsutism is medical therapy. Surgery is usually reserved for patients with either:
- Ovarian tumor[1]
- Adrenal tumor[1]
- Perimenopausal or postmenopausal women with severe hyperandrogenism are candidated for oophorectomy[2][3]
- Bariatric surgery is an additional option for PCOS women with severe obesity or obesity with metabolic comorbidities[4][5]
References
- ↑ 1.0 1.1 Franks, Stephen (2012). "The investigation and management of hirsutism". Journal of Family Planning and Reproductive Health Care. 38 (3): 182–186. doi:10.1136/jfprhc-2011-100175. ISSN 1471-1893.
- ↑ Souto SB, Baptista PV, Braga DC, Carvalho D (2014). "Ovarian Leydig cell tumor in a post-menopausal patient with severe hyperandrogenism". Arq Bras Endocrinol Metabol. 58 (1): 68–75. PMID 24728167.
- ↑ Klotz RK, Müller-Holzner E, Fessler S, Reimer DU, Zervomanolakis I, Seeber B; et al. (2010). "Leydig-cell-tumor of the ovary that responded to GnRH-analogue administration - case report and review of the literature". Exp Clin Endocrinol Diabetes. 118 (5): 291–7. doi:10.1055/s-0029-1225351. PMID 20198556.
- ↑ Fauser BC, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, Carmina E, Chang J, Yildiz BO, Laven JS, Boivin J, Petraglia F, Wijeyeratne CN, Norman RJ, Dunaif A, Franks S, Wild RA, Dumesic D, Barnhart K (2012). "Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group". Fertil. Steril. 97 (1): 28–38.e25. doi:10.1016/j.fertnstert.2011.09.024. PMID 22153789.
- ↑ Spritzer PM (2014). "Polycystic ovary syndrome: reviewing diagnosis and management of metabolic disturbances". Arq Bras Endocrinol Metabol. 58 (2): 182–7. PMID 24830595.